Association of statin use with clinical outcomes in patients with triple-negative breast cancer.
Malgorzata K NowakowskaXiudong LeiMikayla T ThompsonSimona F ShaitelmanMackenzie R WehnerWendy A WoodwardSharon H GiordanoKevin T NeadPublished in: Cancer (2021)
Among women with I, II, and III TNBC, initiation of statin therapy in the 12 months after breast cancer diagnosis was associated with an OS and BCSS benefit. Statins may have a role in select patients with breast cancer, and further investigation is warranted.